104 related articles for article (PubMed ID: 28546999)
21. Activation of the intronic cryptic 5' splice site depends on its distance to the upstream cassette exon.
Liu W; Li X; Liao S; Dou K; Zhang Y
Gene; 2017 Jul; 619():30-36. PubMed ID: 28322992
[TBL] [Abstract][Full Text] [Related]
22. Compound heterozygous DUOX2 gene mutations (c.2335-1G>C/c.3264_3267delCAGC) associated with congenital hypothyroidism. Characterization of complex cryptic splice sites by minigene analysis.
Belforte FS; Citterio CE; Testa G; Olcese MC; Sobrero G; Miras MB; Targovnik HM; Rivolta CM
Mol Cell Endocrinol; 2016 Jan; 419():172-84. PubMed ID: 26506010
[TBL] [Abstract][Full Text] [Related]
23. Mutation of acceptor splice site of the SEDL gene in X-linked spondyloepiphyseal dysplasia tarda causes the activation of cryptic splice site.
Ma HW; Jiang J; Lu JF; Guo R; Niu GH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):251-3. PubMed ID: 15952107
[TBL] [Abstract][Full Text] [Related]
24. Two intronic mutations cause 17-hydroxylase deficiency by disrupting splice acceptor sites: direct demonstration of aberrant splicing and absent enzyme activity by expression of the entire CYP17 gene in HEK-293 cells.
Costa-Santos M; Kater CE; Dias EP; Auchus RJ
J Clin Endocrinol Metab; 2004 Jan; 89(1):43-8. PubMed ID: 14715826
[TBL] [Abstract][Full Text] [Related]
25. BRCA2 deep intronic mutation causing activation of a cryptic exon: opening toward a new preventive therapeutic strategy.
Anczuków O; Buisson M; Léoné M; Coutanson C; Lasset C; Calender A; Sinilnikova OM; Mazoyer S
Clin Cancer Res; 2012 Sep; 18(18):4903-9. PubMed ID: 22753590
[TBL] [Abstract][Full Text] [Related]
26. Splicing Defects in the AAAS Gene Leading to both Exon Skipping and Partial Intron Retention in a Tunisian Patient with Allgrove Syndrome.
Kallabi F; Ben Rhouma B; Baklouti S; Ghorbel R; Felhi R; Keskes L; Kamoun H
Horm Res Paediatr; 2016; 86(2):90-93. PubMed ID: 27414811
[TBL] [Abstract][Full Text] [Related]
27. Structural study of the 5' end of a synthetic premessenger RNA from adenovirus. Evidence for a long-range exon-intron interaction.
Gallinaro H; Domenjoud L; Jacob M
J Mol Biol; 1994 Jul; 240(3):205-25. PubMed ID: 8028005
[TBL] [Abstract][Full Text] [Related]
28. The architecture of pre-mRNAs affects mechanisms of splice-site pairing.
Fox-Walsh KL; Dou Y; Lam BJ; Hung SP; Baldi PF; Hertel KJ
Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16176-81. PubMed ID: 16260721
[TBL] [Abstract][Full Text] [Related]
29. Mutational analysis of the U12-dependent branch site consensus sequence.
Brock JE; Dietrich RC; Padgett RA
RNA; 2008 Nov; 14(11):2430-9. PubMed ID: 18824513
[TBL] [Abstract][Full Text] [Related]
30. A 6-bp deletion at the splice donor site of the first intron resulted in aberrant splicing using a cryptic splice site within exon 1 in a patient with succinyl-CoA: 3-Ketoacid CoA transferase (SCOT) deficiency.
Fukao T; Sakurai S; Rolland MO; Zabot MT; Schulze A; Yamada K; Kondo N
Mol Genet Metab; 2006 Nov; 89(3):280-2. PubMed ID: 16765626
[TBL] [Abstract][Full Text] [Related]
31. Two silent substitutions in the PDHA1 gene cause exon 5 skipping by disruption of a putative exonic splicing enhancer.
Boichard A; Venet L; Naas T; Boutron A; Chevret L; de Baulny HO; De Lonlay P; Legrand A; Nordman P; Brivet M
Mol Genet Metab; 2008 Mar; 93(3):323-30. PubMed ID: 18023225
[TBL] [Abstract][Full Text] [Related]
32. Defective pre-mRNA splicing in PKD1 due to presumed missense and synonymous mutations causing autosomal dominant polycystic disease.
Gonzalez-Paredes FJ; Ramos-Trujillo E; Claverie-Martin F
Gene; 2014 Aug; 546(2):243-9. PubMed ID: 24907393
[TBL] [Abstract][Full Text] [Related]
33. Why Selection Might Be Stronger When Populations Are Small: Intron Size and Density Predict within and between-Species Usage of Exonic Splice Associated cis-Motifs.
Wu X; Hurst LD
Mol Biol Evol; 2015 Jul; 32(7):1847-61. PubMed ID: 25771198
[TBL] [Abstract][Full Text] [Related]
34. Clinical and genetic studies of CLCN5 mutations in Japanese families with Dent's disease.
Igarashi T; Inatomi J; Ohara T; Kuwahara T; Shimadzu M; Thakker RV
Kidney Int; 2000 Aug; 58(2):520-7. PubMed ID: 10916075
[TBL] [Abstract][Full Text] [Related]
35. Reported in vivo splice-site mutations in the factor IX gene: severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations.
Ketterling RP; Drost JB; Scaringe WA; Liao DZ; Liu JZ; Kasper CK; Sommer SS
Hum Mutat; 1999; 13(3):221-31. PubMed ID: 10090477
[TBL] [Abstract][Full Text] [Related]
36. Prevalence, parameters, and pathogenic mechanisms for splice-altering acceptor variants that disrupt the AG exclusion zone.
Bryen SJ; Yuen M; Joshi H; Dawes R; Zhang K; Lu JK; Jones KJ; Liang C; Wong WK; Peduto AJ; Waddell LB; Evesson FJ; Cooper ST
HGG Adv; 2022 Oct; 3(4):100125. PubMed ID: 35847480
[TBL] [Abstract][Full Text] [Related]
37. Modulation of prion protein expression through cryptic splice site manipulation.
Gentile JE; Corridon TL; Mortberg MA; D'Souza EN; Whiffin N; Minikel EV; Vallabh SM
bioRxiv; 2023 Dec; ():. PubMed ID: 38187635
[TBL] [Abstract][Full Text] [Related]
38. Do non-genomically encoded fusion transcripts cause recurrent chromosomal translocations?
Kowarz E; Dingermann T; Marschalek R
Cancers (Basel); 2012 Oct; 4(4):1036-49. PubMed ID: 24213499
[TBL] [Abstract][Full Text] [Related]
39. Reversion of the Arabidopsis rpn12a-1 exon-trap mutation by an intragenic suppressor that weakens the chimeric 5' splice site.
Kurepa J; Li Y; Smalle JA
F1000Res; 2013; 2():60. PubMed ID: 24358894
[TBL] [Abstract][Full Text] [Related]
40. Splice site and
Chou SR; Bailey AC; Baysac K; Oler AJ; Milner JD; Ombrello MJ
medRxiv; 2024 Mar; ():. PubMed ID: 38562814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]